Novel Agents for Indolent Lymphoma and Mantle Cell Lymphoma Stephen Ansell, MD, PhD Mayo Clinic.
Novel Agents for Indolent L ymphoma and Mantle Cell Lymphoma
CALGB 100104 A Phase III Randomized, Double-Blind Study of Maintenance Therapy With Lenalidomide (CC 5013) or Placebo Following Autologous Stem Cell Transplantation.